Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
27 Leser
Artikel bewerten:
(0)

Global Biosurgery Market Analysis, Trends & Industry Forecasts to 2025 - Research and Markets

DUBLIN, August 11, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Biosurgery Market Analysis & Trends - Industry Forecast to 2025" report to their offering.

The Global Biosurgery Market is poised to grow at a CAGR of around 8.3% over the next decade to reach approximately $16.2 billion by 2025.

This industry report analyzes the global markets for Biosurgery across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing Availability of Multifunctional Products
3.1.2 Increasing number of new therapeutic options generated by the biotechnology
3.1.3 Recent Techlological Developments of Biosurgeries
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness

4 Biosurgery Market, By Application
4.1 Neurological Surgeries
4.2 General Surgeries
4.3 Cardiovascular Surgeries
4.4 Orthopedic Surgeries
4.5 Thoracic Surgeries
4.6 Gynecology Surgeries
4.7 Reconstructive Surgeries
4.8 Urology Surgeries

5 Biosurgery Market, By Source
5.1 Biologics Products
5.2 Synthetics Products

6 Biosurgery Market, By Product Type
6.1 Adhesion Barriers
6.2 Anti-adhesive agents
6.3 Hemostatic Agents
6.4 Staple Line Reinforcement Agents
6.5 Surgical Sealants
6.6 Bone Graft Subsitutes
6.7 Soft-Tissue Attachments (Soft Tissue Patch/Mesh)

7 Biosurgery Market, By Geography

8 Leading Companies

- Atrium Medical Corporation (Maquet Getinge Group)
- B. Braun Melsungen AG
- Baxter International Inc.
- C. R. Bard Inc.
- Covidien PLC
- Cryolife Inc.
- Hemostasis LLC
- Johnson and Johnson
- Kuros Bioscience
- Medtronic PLC
- Sanofi S.A.
- Stryker Corporation

For more information visit http://www.researchandmarkets.com/research/2gpvxn/global_biosurgery

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.